カテゴリー： Market Monitor Global, 世界, 医療/バイオ

動物/ヒト血清の世界市場見通し2023年-2029年

◆英語タイトル：Animal and Human Serum Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB2242）◆商品コード：MMG23FB2242
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の動物/ヒト血清市場規模と予測を収録しています。・世界の動物/ヒト血清市場：売上、2018年-2023年、2024年-2029年
・世界の動物/ヒト血清市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の動物/ヒト血清市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ヒト血清アルブミン（HAS）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

動物/ヒト血清のグローバル主要企業は、Grifols、Baxter、Animal Technologies、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang、Thermo Fisher、Merck、Cytiva、Biowest、Moregate BioTech、ExCell Bio、Internegocios、Tissue Culture Biologicals、Gemini、Corning、Biological Industries、VWR、Bovogen、R&D Systems、Seroxlabなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、動物/ヒト血清のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の動物/ヒト血清市場：タイプ別、2018年-2023年、2024年-2029年
世界の動物/ヒト血清市場：タイプ別市場シェア、2022年
・ヒト血清アルブミン（HAS）、ウシ胎児血清（FBS）、その他

世界の動物/ヒト血清市場：用途別、2018年-2023年、2024年-2029年
世界の動物/ヒト血清市場：用途別市場シェア、2022年
・病院・診療所、診療所、その他

世界の動物/ヒト血清市場：地域・国別、2018年-2023年、2024年-2029年
世界の動物/ヒト血清市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における動物/ヒト血清のグローバル売上、2018年-2023年
・主要企業における動物/ヒト血清のグローバル売上シェア、2022年
・主要企業における動物/ヒト血清のグローバル販売量、2018年-2023年
・主要企業における動物/ヒト血清のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Grifols、Baxter、Animal Technologies、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang、Thermo Fisher、Merck、Cytiva、Biowest、Moregate BioTech、ExCell Bio、Internegocios、Tissue Culture Biologicals、Gemini、Corning、Biological Industries、VWR、Bovogen、R&D Systems、Seroxlab

*************************************************************

・調査・分析レポートの概要
動物/ヒト血清市場の定義
市場セグメント
世界の動物/ヒト血清市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の動物/ヒト血清市場規模
世界の動物/ヒト血清市場規模：2022年 VS 2029年
世界の動物/ヒト血清市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの動物/ヒト血清の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の動物/ヒト血清製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ヒト血清アルブミン（HAS）、ウシ胎児血清（FBS）、その他
動物/ヒト血清のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院・診療所、診療所、その他
動物/ヒト血清の用途別グローバル売上・予測

・地域別市場分析
地域別動物/ヒト血清市場規模 2022年と2029年
地域別動物/ヒト血清売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Grifols、Baxter、Animal Technologies、CSL、Octapharma、Biotest、Kedrion、Hualan Bio、CNBG、Shanghai RAAS、CBPO、LFB Group、BPL、Sichuan Yuanda Shuyang、Thermo Fisher、Merck、Cytiva、Biowest、Moregate BioTech、ExCell Bio、Internegocios、Tissue Culture Biologicals、Gemini、Corning、Biological Industries、VWR、Bovogen、R&D Systems、Seroxlab
...

This report aims to provide a comprehensive presentation of the global market for Animal and Human Serum, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal and Human Serum. This report contains market size and forecasts of Animal and Human Serum in global, including the following market information:
Global Animal and Human Serum Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Animal and Human Serum Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Animal and Human Serum companies in 2022 (%)
The global Animal and Human Serum market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Serum Albumin (HSA) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Animal and Human Serum include Grifols, Baxter, Animal Technologies, CSL, Octapharma, Biotest, Kedrion, Hualan Bio and CNBG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Animal and Human Serum manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Animal and Human Serum Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal and Human Serum Market Segment Percentages, by Type, 2022 (%)
Human Serum Albumin (HSA)
Fetal Bovine Serum (FBS)
Other
Global Animal and Human Serum Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal and Human Serum Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Diagnostic Laboratories
Others
Global Animal and Human Serum Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Animal and Human Serum Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal and Human Serum revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Animal and Human Serum revenues share in global market, 2022 (%)
Key companies Animal and Human Serum sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Animal and Human Serum sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols
Baxter
Animal Technologies
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
Outline of Major Chapters:
Chapter 1: Introduces the definition of Animal and Human Serum, market overview.
Chapter 2: Global Animal and Human Serum market size in revenue and volume.
Chapter 3: Detailed analysis of Animal and Human Serum manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Animal and Human Serum in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Animal and Human Serum capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Animal and Human Serum Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Animal and Human Serum Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Animal and Human Serum Overall Market Size
2.1 Global Animal and Human Serum Market Size: 2022 VS 2029
2.2 Global Animal and Human Serum Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Animal and Human Serum Sales: 2018-2029
3 Company Landscape
3.1 Top Animal and Human Serum Players in Global Market
3.2 Top Global Animal and Human Serum Companies Ranked by Revenue
3.3 Global Animal and Human Serum Revenue by Companies
3.4 Global Animal and Human Serum Sales by Companies
3.5 Global Animal and Human Serum Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Animal and Human Serum Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Animal and Human Serum Product Type
3.8 Tier 1, Tier 2 and Tier 3 Animal and Human Serum Players in Global Market
3.8.1 List of Global Tier 1 Animal and Human Serum Companies
3.8.2 List of Global Tier 2 and Tier 3 Animal and Human Serum Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Animal and Human Serum Market Size Markets, 2022 & 2029
4.1.2 Human Serum Albumin (HSA)
4.1.3 Fetal Bovine Serum (FBS)
4.1.4 Other
4.2 By Type – Global Animal and Human Serum Revenue & Forecasts
4.2.1 By Type – Global Animal and Human Serum Revenue, 2018-2023
4.2.2 By Type – Global Animal and Human Serum Revenue, 2024-2029
4.2.3 By Type – Global Animal and Human Serum Revenue Market Share, 2018-2029
4.3 By Type – Global Animal and Human Serum Sales & Forecasts
4.3.1 By Type – Global Animal and Human Serum Sales, 2018-2023
4.3.2 By Type – Global Animal and Human Serum Sales, 2024-2029
4.3.3 By Type – Global Animal and Human Serum Sales Market Share, 2018-2029
4.4 By Type – Global Animal and Human Serum Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Animal and Human Serum Market Size, 2022 & 2029
5.1.2 Hospitals and Clinics
5.1.3 Diagnostic Laboratories
5.1.4 Others
5.2 By Application – Global Animal and Human Serum Revenue & Forecasts
5.2.1 By Application – Global Animal and Human Serum Revenue, 2018-2023
5.2.2 By Application – Global Animal and Human Serum Revenue, 2024-2029
5.2.3 By Application – Global Animal and Human Serum Revenue Market Share, 2018-2029
5.3 By Application – Global Animal and Human Serum Sales & Forecasts
5.3.1 By Application – Global Animal and Human Serum Sales, 2018-2023
5.3.2 By Application – Global Animal and Human Serum Sales, 2024-2029
5.3.3 By Application – Global Animal and Human Serum Sales Market Share, 2018-2029
5.4 By Application – Global Animal and Human Serum Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Animal and Human Serum Market Size, 2022 & 2029
6.2 By Region – Global Animal and Human Serum Revenue & Forecasts
6.2.1 By Region – Global Animal and Human Serum Revenue, 2018-2023
6.2.2 By Region – Global Animal and Human Serum Revenue, 2024-2029
6.2.3 By Region – Global Animal and Human Serum Revenue Market Share, 2018-2029
6.3 By Region – Global Animal and Human Serum Sales & Forecasts
6.3.1 By Region – Global Animal and Human Serum Sales, 2018-2023
6.3.2 By Region – Global Animal and Human Serum Sales, 2024-2029
6.3.3 By Region – Global Animal and Human Serum Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Animal and Human Serum Revenue, 2018-2029
6.4.2 By Country – North America Animal and Human Serum Sales, 2018-2029
6.4.3 US Animal and Human Serum Market Size, 2018-2029
6.4.4 Canada Animal and Human Serum Market Size, 2018-2029
6.4.5 Mexico Animal and Human Serum Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Animal and Human Serum Revenue, 2018-2029
6.5.2 By Country – Europe Animal and Human Serum Sales, 2018-2029
6.5.3 Germany Animal and Human Serum Market Size, 2018-2029
6.5.4 France Animal and Human Serum Market Size, 2018-2029
6.5.5 U.K. Animal and Human Serum Market Size, 2018-2029
6.5.6 Italy Animal and Human Serum Market Size, 2018-2029
6.5.7 Russia Animal and Human Serum Market Size, 2018-2029
6.5.8 Nordic Countries Animal and Human Serum Market Size, 2018-2029
6.5.9 Benelux Animal and Human Serum Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Animal and Human Serum Revenue, 2018-2029
6.6.2 By Region – Asia Animal and Human Serum Sales, 2018-2029
6.6.3 China Animal and Human Serum Market Size, 2018-2029
6.6.4 Japan Animal and Human Serum Market Size, 2018-2029
6.6.5 South Korea Animal and Human Serum Market Size, 2018-2029
6.6.6 Southeast Asia Animal and Human Serum Market Size, 2018-2029
6.6.7 India Animal and Human Serum Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Animal and Human Serum Revenue, 2018-2029
6.7.2 By Country – South America Animal and Human Serum Sales, 2018-2029
6.7.3 Brazil Animal and Human Serum Market Size, 2018-2029
6.7.4 Argentina Animal and Human Serum Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Animal and Human Serum Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Animal and Human Serum Sales, 2018-2029
6.8.3 Turkey Animal and Human Serum Market Size, 2018-2029
6.8.4 Israel Animal and Human Serum Market Size, 2018-2029
6.8.5 Saudi Arabia Animal and Human Serum Market Size, 2018-2029
6.8.6 UAE Animal and Human Serum Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Grifols
7.1.1 Grifols Company Summary
7.1.2 Grifols Business Overview
7.1.3 Grifols Animal and Human Serum Major Product Offerings
7.1.4 Grifols Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.1.5 Grifols Key News & Latest Developments
7.2 Baxter
7.2.1 Baxter Company Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Animal and Human Serum Major Product Offerings
7.2.4 Baxter Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.2.5 Baxter Key News & Latest Developments
7.3 Animal Technologies
7.3.1 Animal Technologies Company Summary
7.3.2 Animal Technologies Business Overview
7.3.3 Animal Technologies Animal and Human Serum Major Product Offerings
7.3.4 Animal Technologies Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.3.5 Animal Technologies Key News & Latest Developments
7.4 CSL
7.4.1 CSL Company Summary
7.4.2 CSL Business Overview
7.4.3 CSL Animal and Human Serum Major Product Offerings
7.4.4 CSL Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.4.5 CSL Key News & Latest Developments
7.5 Octapharma
7.5.1 Octapharma Company Summary
7.5.2 Octapharma Business Overview
7.5.3 Octapharma Animal and Human Serum Major Product Offerings
7.5.4 Octapharma Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.5.5 Octapharma Key News & Latest Developments
7.6 Biotest
7.6.1 Biotest Company Summary
7.6.2 Biotest Business Overview
7.6.3 Biotest Animal and Human Serum Major Product Offerings
7.6.4 Biotest Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.6.5 Biotest Key News & Latest Developments
7.7 Kedrion
7.7.1 Kedrion Company Summary
7.7.2 Kedrion Business Overview
7.7.3 Kedrion Animal and Human Serum Major Product Offerings
7.7.4 Kedrion Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.7.5 Kedrion Key News & Latest Developments
7.8 Hualan Bio
7.8.1 Hualan Bio Company Summary
7.8.2 Hualan Bio Business Overview
7.8.3 Hualan Bio Animal and Human Serum Major Product Offerings
7.8.4 Hualan Bio Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.8.5 Hualan Bio Key News & Latest Developments
7.9 CNBG
7.9.1 CNBG Company Summary
7.9.2 CNBG Business Overview
7.9.3 CNBG Animal and Human Serum Major Product Offerings
7.9.4 CNBG Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.9.5 CNBG Key News & Latest Developments
7.10 Shanghai RAAS
7.10.1 Shanghai RAAS Company Summary
7.10.2 Shanghai RAAS Business Overview
7.10.3 Shanghai RAAS Animal and Human Serum Major Product Offerings
7.10.4 Shanghai RAAS Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.10.5 Shanghai RAAS Key News & Latest Developments
7.11 CBPO
7.11.1 CBPO Company Summary
7.11.2 CBPO Animal and Human Serum Business Overview
7.11.3 CBPO Animal and Human Serum Major Product Offerings
7.11.4 CBPO Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.11.5 CBPO Key News & Latest Developments
7.12 LFB Group
7.12.1 LFB Group Company Summary
7.12.2 LFB Group Animal and Human Serum Business Overview
7.12.3 LFB Group Animal and Human Serum Major Product Offerings
7.12.4 LFB Group Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.12.5 LFB Group Key News & Latest Developments
7.13 BPL
7.13.1 BPL Company Summary
7.13.2 BPL Animal and Human Serum Business Overview
7.13.3 BPL Animal and Human Serum Major Product Offerings
7.13.4 BPL Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.13.5 BPL Key News & Latest Developments
7.14 Sichuan Yuanda Shuyang
7.14.1 Sichuan Yuanda Shuyang Company Summary
7.14.2 Sichuan Yuanda Shuyang Business Overview
7.14.3 Sichuan Yuanda Shuyang Animal and Human Serum Major Product Offerings
7.14.4 Sichuan Yuanda Shuyang Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.14.5 Sichuan Yuanda Shuyang Key News & Latest Developments
7.15 Thermo Fisher
7.15.1 Thermo Fisher Company Summary
7.15.2 Thermo Fisher Business Overview
7.15.3 Thermo Fisher Animal and Human Serum Major Product Offerings
7.15.4 Thermo Fisher Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.15.5 Thermo Fisher Key News & Latest Developments
7.16 Merck
7.16.1 Merck Company Summary
7.16.2 Merck Business Overview
7.16.3 Merck Animal and Human Serum Major Product Offerings
7.16.4 Merck Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.16.5 Merck Key News & Latest Developments
7.17 Cytiva
7.17.1 Cytiva Company Summary
7.17.2 Cytiva Business Overview
7.17.3 Cytiva Animal and Human Serum Major Product Offerings
7.17.4 Cytiva Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.17.5 Cytiva Key News & Latest Developments
7.18 Biowest
7.18.1 Biowest Company Summary
7.18.2 Biowest Business Overview
7.18.3 Biowest Animal and Human Serum Major Product Offerings
7.18.4 Biowest Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.18.5 Biowest Key News & Latest Developments
7.19 Moregate BioTech
7.19.1 Moregate BioTech Company Summary
7.19.2 Moregate BioTech Business Overview
7.19.3 Moregate BioTech Animal and Human Serum Major Product Offerings
7.19.4 Moregate BioTech Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.19.5 Moregate BioTech Key News & Latest Developments
7.20 ExCell Bio
7.20.1 ExCell Bio Company Summary
7.20.2 ExCell Bio Business Overview
7.20.3 ExCell Bio Animal and Human Serum Major Product Offerings
7.20.4 ExCell Bio Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.20.5 ExCell Bio Key News & Latest Developments
7.21 Internegocios
7.21.1 Internegocios Company Summary
7.21.2 Internegocios Business Overview
7.21.3 Internegocios Animal and Human Serum Major Product Offerings
7.21.4 Internegocios Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.21.5 Internegocios Key News & Latest Developments
7.22 Tissue Culture Biologicals
7.22.1 Tissue Culture Biologicals Company Summary
7.22.2 Tissue Culture Biologicals Business Overview
7.22.3 Tissue Culture Biologicals Animal and Human Serum Major Product Offerings
7.22.4 Tissue Culture Biologicals Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.22.5 Tissue Culture Biologicals Key News & Latest Developments
7.23 Gemini
7.23.1 Gemini Company Summary
7.23.2 Gemini Business Overview
7.23.3 Gemini Animal and Human Serum Major Product Offerings
7.23.4 Gemini Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.23.5 Gemini Key News & Latest Developments
7.24 Corning
7.24.1 Corning Company Summary
7.24.2 Corning Business Overview
7.24.3 Corning Animal and Human Serum Major Product Offerings
7.24.4 Corning Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.24.5 Corning Key News & Latest Developments
7.25 Biological Industries
7.25.1 Biological Industries Company Summary
7.25.2 Biological Industries Business Overview
7.25.3 Biological Industries Animal and Human Serum Major Product Offerings
7.25.4 Biological Industries Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.25.5 Biological Industries Key News & Latest Developments
7.26 VWR
7.26.1 VWR Company Summary
7.26.2 VWR Business Overview
7.26.3 VWR Animal and Human Serum Major Product Offerings
7.26.4 VWR Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.26.5 VWR Key News & Latest Developments
7.27 Bovogen
7.27.1 Bovogen Company Summary
7.27.2 Bovogen Business Overview
7.27.3 Bovogen Animal and Human Serum Major Product Offerings
7.27.4 Bovogen Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.27.5 Bovogen Key News & Latest Developments
7.28 R&D Systems
7.28.1 R&D Systems Company Summary
7.28.2 R&D Systems Business Overview
7.28.3 R&D Systems Animal and Human Serum Major Product Offerings
7.28.4 R&D Systems Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.28.5 R&D Systems Key News & Latest Developments
7.29 Seroxlab
7.29.1 Seroxlab Company Summary
7.29.2 Seroxlab Business Overview
7.29.3 Seroxlab Animal and Human Serum Major Product Offerings
7.29.4 Seroxlab Animal and Human Serum Sales and Revenue in Global (2018-2023)
7.29.5 Seroxlab Key News & Latest Developments
8 Global Animal and Human Serum Production Capacity, Analysis
8.1 Global Animal and Human Serum Production Capacity, 2018-2029
8.2 Animal and Human Serum Production Capacity of Key Manufacturers in Global Market
8.3 Global Animal and Human Serum Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Animal and Human Serum Supply Chain Analysis
10.1 Animal and Human Serum Industry Value Chain
10.2 Animal and Human Serum Upstream Market
10.3 Animal and Human Serum Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Animal and Human Serum Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 動物/ヒト血清の世界市場見通し2023年-2029年(Animal and Human Serum Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 組換えヒトチモシンベータ4タンパク質のグローバル市場展望 2023年-2029年：純度＞85%、純度＞95%、純度＞97%、その他
  • 動物由来コラーゲンドレッシングのグローバル市場展望 2023年-2029年：I型コラーゲン、II型コラーゲン、III型コラーゲン
  • 血清糖化アルブミンアッセイのグローバル市場展望 2023年-2029年：比色分析、免疫分析
  • 抗血清のグローバル市場展望 2023年-2029年：抗毒素血清、抗菌血清、抗ウイルス血清、その他
  • ヒトiPSCの世界市場見通し2023年-2029年